AI-extracted from the 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Q2 net sales reached $2.752B (+9% YoY), driven by pricing actions and favorable currency, though operating profit growth of 19% was tempered by $65M accelerated depreciation from announced facility closures.
Biggest Revenue Drivers
Acetyl Chain$1.329B+19% YoY
Higher pricing due to regional supply dislocation and elevated raw materials costs; favorable currency impact partially offset by lower volume from decreased global demand.
Engineered Materials$1.446B+0.3% YoY
Pricing actions and favorable product mix offset lower volume from completed Micromax® business sale; favorable currency impact from stronger euro and Chinese yuan.
Biggest Revenue Drivers
Total revenue: $2.752B+9% YoY
Acetyl Chain$1.329B+19% YoY
Higher pricing due to regional supply dislocation and elevated raw materials costs; favorable currency impact partially offset by lower volume from decreased global demand.
Engineered Materials$1.446B+0.3% YoY
Pricing actions and favorable product mix offset lower volume from completed Micromax® business sale; favorable currency impact from stronger euro and Chinese yuan.
Largest Expense Items
Cost of sales$2.134B+7% YoY
Higher raw materials costs in Acetyl Chain for ethylene and methanol, partially offset by productivity initiatives and sourcing changes in Engineered Materials.
Accelerated depreciation$65M incremental
Related to announced closures of Sakra, Singapore and Ulsan, South Korea facilities and Lanaken, Belgium facility, and optimization of North American nylon 6,6 units.
Selling, general and administrative expenses$251M+17% YoY
Higher spending primarily from increased incentive compensation and merger and acquisition costs in Other Activities.
Margins: Operating margin expanded to 10.0% from 9.1% YoY despite significant headwinds. Margin improvement driven by pricing actions and favorable product mix outweighed higher raw materials costs and restructuring charges, though ongoing facility closures and accelerated depreciation constrain profitability.
Watch Items from the Filing
Company announced closure of Lanaken, Belgium facility (Acetyl Chain) in H2 2026 with estimated $60M additional exit and shutdown costs through 2027, plus similar announced closures in Singapore and South Korea with $85M accelerated depreciation year-to-date.
Total debt of $12.0B as of June 30, 2026 (down from $12.6B at year-end 2025); company reduced quarterly dividend by ~95% in Q1 2025 and paused share repurchases to prioritize deleveraging after DuPont M&M Acquisition.
Completed sale of Micromax® business for $493M in February 2026 (generating $50M gain); company expects capital expenditures of $300-350M in 2026 focused on stewardship and maintenance.
Operating cash flow declined to $285M for six months ended June 30, 2026 from $447M prior year, driven by $396M unfavorable trade working capital from higher pricing and raw material costs.
14 damage claims filed against Company and other ethylene purchasers in European courts (German and Dutch) stemming from 2020 European Commission settlement; two dismissed as not plausible on July 30, 2026, subject to appeal; estimated impact cannot yet be quantified.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
About Celanese Corp (CE): stock profile, AI score and financials
Celanese Corp (CE) stock profile, AI quality score, and SEC EDGAR financial data, a Materials sector company. 13F Pro's AI-powered ranking engine scores CE at 42.8/100 on a composite quality score built from its SEC filings, placing it at rank #1,991 of 2,925 stocks — the bottom half of the AI-ranked universe. CE scores in the top quartile across revenue scale (86.0), institutional flow (84.6). Areas of concern include revenue growth (15.3) and balance sheet strength (21.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Celanese Corp reports quarterly revenue of $2.8B, net income of $125.0M, an operating margin of 10.0%. Top institutional holders of CE by reported 13-F value include DODGE & COX, BlackRock, NORGES BANK, based on the most recent SEC filings. CE trades on the NYSE exchange and files with the SEC under CIK 1306830. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Celanese Corp directly from SEC EDGAR.